[1]
“Use of levosimendan versus dobutamine when inotropic support is needed in patients with severe acute decompensated chronic heart failure”, UJC, vol. 27, no. 6, pp. 47–60, Feb. 2021, doi: 10.31928/1608-635X-2020.6.4760.